Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

unknown125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans

NCT02221089
completednot_applicable

Effect of Antioxidants on Oxygen Induced Vasoconstriction in Lipopolysaccharide (LPS) Induced Inflammatory Model in Humans

NCT00914576
completednot_applicable

Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls

NCT00412906
unknownnot_applicable

Study of Renal Blood Flow During Human Endotoxemia

NCT00413465

Clinical Trials (4)

Showing 4 of 4 trials
NCT02221089Not Applicable

Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans

Completed
NCT00914576Not Applicable

Effect of Antioxidants on Oxygen Induced Vasoconstriction in Lipopolysaccharide (LPS) Induced Inflammatory Model in Humans

Completed
NCT00412906Not Applicable

Study of Gene Activity in Fat and Muscle in Diabetics and Healthy Controls

Completed
NCT00413465Not Applicable

Study of Renal Blood Flow During Human Endotoxemia

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4